📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer. (2023)

First Author: Wills C

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/gcc.23133

PubMed Identifier: 36790221

Publication URI: http://europepmc.org/abstract/MED/36790221

Type: Journal Article/Review

Volume: 62

Parent Publication: Genes, chromosomes & cancer

Issue: 6

ISSN: 1045-2257